Prodotto aggiunto correttamente al carrello.

discount label
H-SIINFEKL-cysteamide
Visualizzare in 3D

Biosynth logo

H-SIINFEKL-cysteamide

Rif. 3D-PP44916

Dimensione non definitaPrezzo su richiesta
Consegna stimata in Stati Uniti, il Lunedì 02 Dicembre 2024

Informazioni sul prodotto

Nome:
H-SIINFEKL-cysteamide
Sinonimi:
  • NH2-Ser-Ile-Ile-Asn-Phe-Glu-Lys-Leu-cysteamide
Descrizione:

Peptide H-SIINFEKL-cysteamide is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SIINFEKL-cysteamide include the following: Improvement of peptide-based tumor immunotherapy using pH-sensitive fusogenic polymer-modified liposomes Y Yoshizaki, E Yuba , T Komatsu, K Udaka, A Harada - Molecules, 2016 - mdpi.comhttps://www.mdpi.com/1420-3049/21/10/1284 A supramolecular vaccine platform based on alpha-helical peptide nanofibers Y Wu , PK Norberg, EA Reap , KL Congdon - ACS biomaterials , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsbiomaterials.7b00561 Peptide-based cancer vaccine delivery via the STINGΔTM-cGAMP complex Y He , C Hong , SJ Fletcher, AG Berger - Advanced , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202200905 Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides XY Mo, P Cascio, K Lemerise - The Journal of , 1999 - journals.aai.orghttps://journals.aai.org/jimmunol/article/163/11/5851/44134 Endogenous viral antigen processing generates peptide-specific MHC class I cell-surface clusters X Lu, JS Gibbs, HD Hickman , A David - Proceedings of the , 2012 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1208696109 Mouse urinary peptides provide a molecular basis for genotype discrimination by nasal sensory neurons T Sturm, T Leinders-Zufall , B Maček , M Walzer - Nature , 2013 - nature.comhttps://www.nature.com/articles/ncomms2610 Short peptide sequences containing MHC class I and/or class II epitopes linked to nano-beads induce strong immunity and inhibition of growth of antigen-specific T Fifis, P Mottram, V Bogdanoska, J Hanley - Vaccine, 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X0400427X of peptide-specific CTL activity and inhibition of tumor growth following immunization with nanoparticles coated with tumor peptide-MHC-I complexes SH Kim, HE Park, SU Jeong, JH Moon, YR Lee - Immune , 2021 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733191/ Well-Defined Mannosylated Polymer for Peptide Vaccine Delivery with Enhanced Antitumor Immunity S Lv , K Song , A Yen , DJ Peeler - Advanced , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202101651 Steroid-peptide immunoconjugates for attenuating T cell responses in an experimental autoimmune encephalomyelitis murine model of multiple sclerosis RW Sands, I Tabansky , CS Verbeke - Bioconjugate , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.bioconjchem.0c00582 Controlled intracellular release of peptides from microcapsules enhances antigen presentation on MHC class I molecules R Palankar , AG Skirtach , O Kreft, M Bedard, M Garstka - Small, 2009 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/smll.200900809 Tapasin edits peptides on MHC class I molecules by accelerating peptide exchange PVK Praveen, R Yaneva, H Kalbacher - European journal of , 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200939342 Processing of exogenous antigens for presentation by class I MHC molecules involves post-Golgi peptide exchange influenced by peptide-MHC complex stability and PJ Chefalo, CV Harding - The Journal of Immunology, 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/167/3/1274/35053 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide P Cascio, C Hilton , AF Kisselev, KL Rock - The EMBO , 2001 - embopress.orghttps://www.embopress.org/doi/full/10.1093/emboj/20.10.2357 Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes NAW Lemmermann , K Gergely, V Böhm - Journal of , 2010 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02087-09 Comparative immunogenicity of a cytotoxic T cell epitope delivered by penetratin and TAT cell penetrating peptides N Brooks, S Esparon, D Pouniotis, GA Pietersz - Molecules, 2015 - mdpi.comhttps://www.mdpi.com/1420-3049/20/8/14033 Covalent conjugation of peptide antigen to mesoporous silica rods to enhance cellular responses MO Dellacherie , AW Li, BY Lu - Bioconjugate , 2018 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.bioconjchem.7b00656 TAP-dependent and-independent peptide import into dendritic cell phagosomes M Lawand , A Abramova, V Manceau - The Journal of , 2016 - journals.aai.orghttps://journals.aai.org/jimmunol/article/197/9/3454/109168 Ovalbumin epitope SIINFEKL self-assembles into a supramolecular hydrogel M Kamalov , H Kahlig, C Rentenberger, ARM Mullner - Scientific Reports, 2019 - nature.comhttps://www.nature.com/articles/s41598-019-39148-8 Tapasin enhances MHC class I peptide presentation according to peptide half-life M Howarth , A Williams, AB Tolstrup - Proceedings of the , 2004 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0306294101 Proteasomes and antigen presentation: evidence that a KEKE motif does not promote presentation of the class I epitope SIINFEKL M Gonciarz-Swiatek, M Rechsteiner - Molecular immunology, 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0161589005004104 Sortase-mediated modification of alphaDEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes LK Swee, CP Guimaraes, S Sehrawat - Proceedings of the , 2013 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1214994110 In vivo generation of cytotoxic T cells from epitopes displayed on peptide-based delivery vehicles KS Kawamura, RC Su , LT Nguyen - The Journal of , 2002 - journals.aai.orghttps://journals.aai.org/jimmunol/article/168/11/5709/34240 Both human and mouse cells expressing H-2Kb and ovalbumin process the same peptide, SIINFEKL K Falk, O Rötzschke , S Faath, S Goth, I Graef - Cellular , 1993 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874983712128 Interferon-γ can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase J Beninga, KL Rock, AL Goldberg - Journal of Biological Chemistry, 1998 - ASBMBhttps://www.jbc.org/article/S0021-9258(18)80196-X/abstract 1379 Novel backbone-modified analogues of antigenic peptides improve immunogenic capabilities of anti-tumor peptide vaccines I Rastogi , R Gibadullin , SH Gellman , D McNeel - 2023 - jitc.bmj.comhttps://jitc.bmj.com/content/11/Suppl_1/A1534.abstract A 16-mer peptide (RQIKIWFQNRRMKWKK) from antennapedia preferentially targets the Class I pathway GA Pietersz, W Li, V Apostolopoulos - Vaccine, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X0000373X Poly (propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines F Qiu , KW Becker , FC Knight, JJ Baljon , S Sevimli - Biomaterials, 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S014296121830543X Identities of P2 and P3 Residues of H-2Kb-Bound Peptides Determine Mouse Ly49C Recognition EA Marquez, KP Kane - PLoS One, 2015 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0131308 Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway DS Pouniotis, V Apostolopoulos , GA Pietersz - Immunology, 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2567.2005.02304.x Comparison of protein and peptide targeting for the development of a CD169-based vaccination strategy against melanoma D Van Dinther , H Veninga, M Revet - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2018.01997/full Generation of both MHC class I-and class II-restricted antigenic peptides from exogenously added ovalbumin in murine phagosomes D Muno, E Kominami, T Mizuochi - FEBS letters, 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0014579300018494 Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2) CL Nguyen, ML Salem , MP Rubinstein, M Demcheva - Vaccine, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X03000963 Role of linker length and antigen density in nanoparticle peptide vaccine CH Kapadia , S Tian, JL Perry , JC Luft - ACS omega, 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsomega.8b03391 Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines C Aguilar-Gurrieri , A Barajas, C Rovirosa - Cancer Immunology , 2023 - Springerhttps://link.springer.com/article/10.1007/s00262-023-03409-3 T cell determinants incorporating beta-amino acid residues are protease resistant and remain immunogenic in vivo AI Webb , MA Dunstone , NA Williamson - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/175/6/3810/73297 Optimisation of peptide-based cytotoxic T-cell determinants using AI Webb , M Aguilar , AW Purcell - Letters in Peptide Science, 2003 - Springerhttps://link.springer.com/article/10.1007/s10989-004-2427-2 for a novel luminal endoplasmic reticulum aminopeptidase in final trimming of 26 S proteasome-generated major histocompatability complex class I antigenic peptides A Komlosh, F Momburg , T Weinschenk - Journal of Biological , 2001 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)89708-7/abstract Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide A Craiu, T Akopian, A Goldberg - Proceedings of the , 1997 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.94.20.10850

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP44916 H-SIINFEKL-cysteamide

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".